A Proposed Effect of Medimmune v. Genentech on Licensee’s Risk Analysis

What will be the effect of the Supreme Court’s decision in ? I propose that Medimmune will lead to more lawsuits by licensees due to decreased risk on the licensee, but only under certain economic conditions-when the license fee savings from litigating the invalidity and/or noninfringement issues is greater than the attorneys’ fees the licensee

Our Inaugural Post

The District of Delaware has long been a center for intellectual property litigation, drawing parties and law firms from across the nation to the federal courthouse in Wilmington. In 2005, intellectual property filings – patent, copyright, and trademark – outpaced all non-prisoner civil filings in Delaware. Nearly fifteen percent of the dockets of Delaware's four